| Similar Articles |
|---|
 |
Chemistry World
August 20, 2014
Maria Burke |
Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern.   |
Chemistry World
December 3, 2014
Maria Burke |
Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline. |
Chemistry World
October 23, 2014
Rebecca Trager |
US agency fast-tracks Ebola vaccine development The US Department of Health and Human Services is fast-tracking tests on an Ebola vaccine by providing $5.8 million under a one-year contract with the Maryland-based biotech company Profectus BioSciences |
Chemistry World
August 5, 2015
Emma Stoye |
Vaccine raises hopes of an end to Ebola A Phase III trial for a candidate Ebola vaccine has shown extremely encouraging results in Guinea, demonstrating complete protection for all those who were vaccinated. |
Chemistry World
January 19, 2015
Maria Burke |
Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine. |
Chemistry World
January 29, 2015
Matthew Gunther |
Ebola vaccine shown to be safe in humans GlaxoSmithKline's experimental Ebola vaccine is capable of triggering an immune response in humans, according to a new study. |
Chemistry World
April 23, 2015
Tim Wogan |
SiRNA treatment cures Ebola in monkeys The first laboratory trial demonstrating the effectiveness of an experimental drug against the strain of Ebola currently ravaging West Africa has been performed in rhesus monkeys. |
Pharmaceutical Executive
October 1, 2014
Jill Wechsler |
Ebola Crisis Challenges Pharma R&D Companies gain support and pressure to deliver new treatments for spreading outbreak. |
Fast Company
June 2015 |
Meet Ebola's Soft-Spoken, Plant-Loving Arch Nemesis A professor at Arizona State University, Arntzen is considered the godfather of a growing field of research sometimes called "pharming": engineering plants to produce specialized vaccines and other drugs. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
Fast Company
Sarah Kessler |
Why There Is No Available Ebola Vaccine Ebola has the unprofitable qualities of being both relatively rare and infecting a mostly poor population. No pharma company wanted to foot the bill for human trials and production. |
Chemistry World
June 12, 2015
Christopher Barnard |
Drawing order from disorder to unravel Ebola's lethality The virulence of Ebola virus strains appears to be innately linked to the degree of disorder in proteins that form their nucleocapsids. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
The Motley Fool
July 25, 2007
Brian Orelli |
Hopeful Flu Production Technology From Baxter While the clinical trial demonstrating strong immunogenicity for the new vaccine is certainly good news, the continued development of the production technology is probably the more important item for investors. |
Popular Mechanics
September 2006
Ben Harder |
Seeking Immunity Pathogens like West Nile virus show no respect for borders. But a new class of vaccines may soon keep them in check. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Vaccines: Progress in Preventing Bad Bugs Long on the sidelines of pharma R&D, vaccine development is moving to center stage as most of the big pharmas diversify, spreading their risk among the full gamut of revenue sources. |
Popular Mechanics
January 22, 2010
Allie Townsend |
Does Fringe's Virus Eradication Plan Hold Up? Is the show's disease from the deep possible? "No," says Dr. William Blattner, director of The Institute of Human Virology. "But it does make for good TV." |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
The Motley Fool
September 24, 2009
Brian Orelli |
Drugmakers' HIV Treatments Live On Companies that make HIV drugs could lose billions of dollars in revenue if an effective vaccine is developed. All drug-company investors need to keep an eye on up-and-coming drugs from competitors that could take market share. |
Chemistry World
September 16, 2015
Patrick Walter |
A shot in the arm It's heartening news that an Ebola vaccine has delivered outstanding results and that a malaria one shows early promise. |
Chemistry World
November 25, 2015
Philippa Matthews |
'Superballs' can block infection by Ebola virus Molecular 'superballs' have been created that can stop viruses infecting cells. |
Chemistry World
January 6, 2015
Sarah Houlton |
Riding new waves Global annual spending on medicines is set to top $1 trillion for the first time in 2014, having ended 2013 just shy of that figure at $989 billion. |
Scientific American
February 27, 2006
Charles Q. Choi |
Going to Bat Long known as vectors for rabies, bats may be the origin of some of the most deadly emerging viruses. Knowledge that bats can carry dangerous viruses could work to prevent epidemics. |
National Defense
November 2014
Lawrence P. Farrell Jr. |
U.S. Faces Evolving, Unpredictable Threats With a temporary spending measure for fiscal year 2015 scheduled to expire Dec. 11, Congress must act quickly to replace that with a full-year appropriation and fix the fiscal square corner that defense faces in the 2016 budget. |
National Defense
April 2015
Stew Magnuson |
Worldwide Biosurveillance Network Still a Distant Goal Since the anthrax attacks of 2001, the U.S. government's intention has been to create a global disease-monitoring system. |
Chemistry World
July 18, 2014
Melissae Fellet |
Molecular computer calculates Ebola diagnosis A molecular computer could one day simplify analysis of biomedical assays like those used to diagnose Ebola, researchers say. |
